1. |
Boudeau J, Baas AF, Deak M, et al. MO25 alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J, 2003, 22(19): 5102-5114.
|
2. |
Brajenovic M, Joberty G, Küster B, et al. Comprehensive proteomic analysis of human Par protein complexes reveals an interonnected protein network. J Biol Chem, 2004, 279(13): 12804-12811.
|
3. |
Jeyabalan J, Shah M, Viollet B, et al. AMP-activated protein kinase pathway and bone metabolism. J Endocrinol, 2012, 212(3): 277-290.
|
4. |
Bakhshandeh B, Hafizi M, Ghaemi N, et al. Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. Biotechnol Lett, 2012, 34(8): 1579-1587.
|
5. |
Kim KM, Park SJ, Jung SH, et al. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res, 2012, 27(8): 1669-1679.
|
6. |
Laine SK, Alm JJ, Virtanen SP, et al. MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem, 2012, 113(8): 2687-2695.
|
7. |
Chen Q, Liu W, Sinha KM, et al. Identification and characterization of MicroRNAs controlled by the osteoblast-specific transcription factor osterix. PLoS One, 2013, 8(3): e58104.
|
8. |
Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol, 2003, 2(4): 28.
|
9. |
Woods SC, Gotoh K, Clegg DJ. Gender differences in the control of energy homeostasis. Exp Biol Med (Maywood), 2003, 228(10): 1175-1180.
|
10. |
Utting JC, Robins SP, Brandao-Burch A, et al. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res, 2006, 312(10): 1693-1702.
|
11. |
Lee WH, Kim SG. AMPK-dependent metabolic regulation by PPAR agonists. PPAR Research, 2010, (2010): 549101.
|
12. |
Shah M, Kola B, Bataveljic A, et al. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone, 2010, 47(2): 309-319.
|
13. |
Kasai T, Bandow K, Suzuki H, et al. Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol, 2009, 221(3): 740-749.
|
14. |
Jeyabalan J, Shah M, Viollet B, et al. Mice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment. J Endocrinol, 2012, 214(3): 349-358.
|
15. |
Goldoni D, Yarham JM, McGahon MK, et al. A novel dual-fluorescence strategy for functionally validating microRNA targets in 3’ untranslated regions: regulation of the inward rectifier potassium channel K(ir)2.1 by miR-212. Biochem J, 2012, 448(1): 103-113.
|
16. |
Yang B, Guo H, Zhang Y, et al. MicroRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One, 2011, 6(7): e21679.
|
17. |
Wang SS, Huang HY, Chen SZ, et al. Gdf6 induces commitment of pluripotent mesenchymal C3H10T1/2 cells to the adipocyte lineage. FEBS J, 2013. [Epub ahead of print].
|
18. |
Mizutani J, Tokuda H, Matsushima-Nishiwaki R, et al. Involvement of AMP-activated protein kinase in TGF-β-stimulated VEGF synthesis inosteoblasts. Int J Mol Med, 2012, 29(4): 550-556.
|
19. |
Tian Y, Nan Y, Han L, et al. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma. Int J Oncol, 2012, 40(4): 1105-1112.
|
20. |
Wang X, Zhu H, Zhang X, et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res, 2012, 94(2): 379-390.
|
21. |
Redova M, Poprach A, Nekvindova J, et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med, 2012, 10: 55.
|
22. |
Tanaka-Watanabe Y, Asahara H. Joint and microRNA. Nihon Rinsho Meneki Gakkai Kaishi, 2012, 35(6): 447-454.
|
23. |
Ouyang L, Liu P, Yang S, et al. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol, 2013, 30(1): 340.
|
24. |
Hu H, Zhang Y, Cai XH, et al. Changes in microRNA expression in the MG-63 osteosarcoma cell line compared with osteoblasts. Oncol Lett, 2012, 4(5): 1037-1042.
|
25. |
Hassan MQ, Maeda Y, Taipaleenmaki H, et al. miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem, 2012, 287(50): 42084-42092.
|